Sunday, October 9, 2016

Cefepime




In the US, Cefepime (cefepime systemic) is a member of the drug class fourth generation cephalosporins and is used to treat Bacteremia, Febrile Neutropenia, Intraabdominal Infection, Kidney Infections, Nosocomial Pneumonia, Pneumonia, Skin and Structure Infection, Skin Infection and Urinary Tract Infection.

US matches:

  • Cefepime

  • Cefepime Injection

  • Cefepime Hydrochloride

  • Cefepime Hydrochloride and Dextrose

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01DE01

CAS registry number (Chemical Abstracts Service)

0088040-23-7

Chemical Formula

C19-H24-N6-O5-S2

Molecular Weight

480

Therapeutic Category

Antibacterial: Cephalosporin

Chemical Name

1-[[(6R,7R)-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl-1-methylpyrrolidinium hydroxyde, inner salt, 7²-(Z)-(O-methyloxime)

Foreign Names

  • Cefepimum (Latin)
  • Cefepim (German)
  • Cefepime (French)
  • Cefepima (Spanish)

Generic Names

  • Cefepime (OS: BAN, USAN)
  • Céfépime (OS: DCF)
  • BMY 28142 (IS: Bristol-Myers)
  • CFPM (IS)
  • Cefepime Hydrochloride (OS: BAN, USP, USAN)
  • BMY 28142 2HCl.H20 (IS)
  • Cefepime Hydrochloride Monohydrate (IS)
  • Cefepime Dihydrochloride (PH: JP XIV)
  • Cefepime Dihydrochloride Hydrate (PH: JP XV)
  • Cefepime Dihydrochloride Monohydrate (PH: Ph. Eur. 6)
  • Cefepime Hydrochloride (PH: USP 32)
  • Cefepime Hydrochloride Monohydrate (PH: BP 2010)
  • Cefepimi dihydrochloridum monohydricum (PH: Ph. Eur. 6)

Brand Names

  • Aspime
    Biogalenic, Venezuela


  • Cefepima
    GP Pharm, Peru; Infarmasa, Peru


  • Cefepime
    Apotex, Canada; APP, United States; Medigroup, Peru; Sagent Pharmaceuticals, United States; Vitalis, Peru


  • Ceficad
    Cadila, India


  • Cefim
    Hemofarm, Serbia


  • Cefimen-K
    Klonal, Argentina


  • Cepime
    Ranbaxy, Peru


  • Chase
    Shreshtha, India


  • Exepime
    Ferron, Indonesia


  • Fada Cefepime
    Fada, Argentina


  • Forpar
    Unifarma, Latvia


  • Gen 4
    Ibn Sina, Bangladesh


  • Macef
    Bernofarm, Indonesia


  • Maxicef
    Galenika, Serbia


  • Maxilan
    Landson, Indonesia


  • Maxipime
    Bristol Meyers Squibb, Latvia; Bristol-Myers Squibb, Taiwan


  • Megapime
    Exmek, Peru


  • Protec
    Tabuk Pharmaceutical, Oman


  • Topra
    GMP, Georgia


  • Vipime
    Kalbe, Indonesia


  • Xenim
    Opsonin, Bangladesh


  • Actacef
    Actavis, Indonesia


  • Axépim
    Bristol-Myers Squibb, Burkina Faso; Bristol-Myers Squibb, Burundi; Bristol-Myers Squibb, Benin; Bristol-Myers Squibb, Congo; Bristol-Myers Squibb, Cote D'ivoire; Bristol-Myers Squibb, Cameroon; Bristol-Myers Squibb, France; Bristol-Myers Squibb, Gabon; Bristol-Myers Squibb, Guinea; Bristol-Myers Squibb, Mali; Bristol-Myers Squibb, Mauritius; Bristol-Myers Squibb, Niger; Bristol-Myers Squibb, Senegal; Bristol-Myers Squibb, Chad; Bristol-Myers Squibb, Togo; Bristol-Myers Squibb, Zaire


  • Cefdipime
    Renata, Bangladesh


  • Cefepim Sandoz
    Sandoz, Switzerland


  • Cefepima Libra
    Libra, Vietnam


  • Cefepime Alvia
    Alvia, Greece


  • Cefepime Genven
    Genéricos Venezolanos, Venezuela


  • Céfépime Mylan
    Mylan, France


  • Cefepime OrPha
    OrPha, Switzerland


  • Cefepime Richet
    Richet, Argentina


  • Cefepime
    ACS Dobfar Generics, United States; Northia, Argentina; Orchid, United States


  • Ceforim
    Sanbe, Indonesia


  • Cepim
    Polifarma, Italy


  • Cepimax
    Bristol-Myers Squibb, Philippines


  • Cepimex
    Bruno, Italy


  • Efectus
    Altian, Dominican Republic


  • Gazore
    Alkem, Myanmar


  • Gencef
    Genepharm, Greece


  • Interprim
    Interbat, Indonesia


  • Maxcef
    Bristol-Myers Squibb, Argentina; Bristol-Myers Squibb, Brazil; Bristol-Myers Squibb, Israel


  • Maxef
    Salus, Mexico


  • Maxicef
    Pharos, Indonesia


  • Maxinject
    Suan Farma S.A., Greece


  • Maxipime
    Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Chile; Bristol-Myers Squibb, China; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Czech Republic; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Estonia; Bristol-Myers Squibb, Spain; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, Georgia; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Indonesia; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Japan; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, Luxembourg; Bristol-Myers Squibb, Mexico; Bristol-Myers Squibb, Malaysia; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Oman; Bristol-Myers Squibb, Peru; Bristol-Myers Squibb, Poland; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, Serbia; Bristol-Myers Squibb, Russian Federation; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Singapore; Bristol-Myers Squibb, Slovakia; Bristol-Myers Squibb, Turkey; Bristol-Myers Squibb, Venezuela; Bristol-Myers Squibb, Vietnam; Bristol-Myers Squibb, South Africa; Elan, United States; Jadran, Bosnia & Herzegowina; Jadran, Croatia (Hrvatska); PharmaSwiss, Slovenia; Vianex / BIANEΞ, Greece


  • Procepim
    Meprofarm, Indonesia


  • Rapime
    Fahrenheit, Indonesia


  • Sandocef
    Sandoz, Indonesia


  • Sopime
    Soho, Indonesia


  • Ultrapime
    Incepta, Bangladesh


  • Unisef
    Mustafa Nevzat, Turkey

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
USPPharmacopoeia of the United States

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment